from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0693/pqqE

LFCtreatmentdescriptionclass of inhibitor

2.019

Amikacinug/mL Amikacintranslation

0.381

Cap5-10ug/mL Capreomycintranslation

0.981

Rox10-50 ug/mL Roxithromycintranslation

0.944

SM2-5 ug/mL Streptomycintranslation

1.366

Tet5-10 ug/mL Tetracyclinetranslation

-0.140

Rif0.2-5ug/mL Rifampicintranscription

-0.105

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.401

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.989

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.273

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.792

Clofazimine10-13 ug/mL Clofaziminerespiration

0.415

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.368

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.794

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.276

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.238

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.141

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.421

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.089

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.418

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.100

KCN5-20 ug/mL Potassium cyaniderespiration

-1.498

NaN30.2-2 mM Sodium aziderespiration

-0.184

Nigericin50 uM Nigericinrespiration

-0.658

TRC10-150 ug/mL Triclosanrespiration

-1.109

TRZ10-25 ug/mL Thioridazinerespiration

-1.626

Valinomycin0.5-10 uM Valinomycinrespiration

0.556

ZnSO42 mM ZnSO4respiration

-1.495

menadione6-10 ug/mL Menadionerespiration

0.391

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.527

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.204

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.261

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.325

NRP_1Non-replicating persistence stage 1dosRassociated

0.739

Amp0.2mg/mL AmpicillincellWall

0.159

Cephalexin20-100 ug/mL CephalexincellWall

-0.261

Cerulenin0.32-5 ug/mL CerulenincellWall

0.326

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.172

EMB10-20 ug/mL EthambutolcellWall

1.010

Eta12-40 ug/mL EthionamidecellWall

0.811

INH0.2-0.4 ug/mL IsoniazidcellWall

0.437

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.238

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.132

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.288

BZA0.12 mg/mL BenzamidearomaticAmides

-0.122

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.238

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.094

H2O24 mM hydrogen peroxideDNAdamaging

-0.721

Levo10 ug/mL LevofloxacinDNAdamaging

0.289

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.684

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.212

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.561

UVUV-irradiationDNAdamaging

-1.115

ARP41-4 ug/mL Antitubercular compound ARP4?

1.408

Antimycin12.5-50 ug/mL Antimycin A?

0.431

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.670

PA_110-50 ug/mL Antitubercular compound PA-1?

0.618

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.325

PA8240.2-2 ug/mL PA-824?

-1.131

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.571

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.510

Verapamil50 uM Verapamil?

2.161

mercaptoethanol2 mM 2-Mercaptoethanol?

0.799

methoxatin10-20 ug/mL Methoxatin?